TY - JOUR T1 - Assessing immune responses to pneumococcal vaccines JF - Archives of Disease in Childhood JO - Arch Dis Child SP - 648 LP - 649 DO - 10.1136/adc.88.7.648 VL - 88 IS - 7 AU - R Lakshman AU - A R Gennery AU - P D Arkwright AU - T Flood AU - M Abinun AU - G Spickett AU - R Borrows AU - A J Cant AU - P Balmer AU - R Borrow Y1 - 2003/07/01 UR - http://adc.bmj.com/content/88/7/648.abstract N2 - The recent article and letter1,2 discussing recommendations for use of heptavalent pneumococcal conjugate vaccine (Prevenar) for at risk children is timely and interesting. We concur with the authors that further immunogenicity studies are necessary in various high risk groups to demonstrate the best protective schedule.Children older than 2 years with recurrent infections and normal humoral immunity assessed by serum immunoglobulin levels and specific antibody responses to protein antigens, but repeated … ER -